Author:
Schmitz Kathryn H.,Williams Nancy I.,Kontos Despina,Domchek Susan,Morales Knashawn H.,Hwang Wei-Ting,Grant Lorita L.,DiGiovanni Laura,Salvatore Domenick,Fenderson Desire’,Schnall Mitchell,Galantino Mary Lou,Stopfer Jill,Kurzer Mindy S.,Wu Shandong,Adelman Jessica,Brown Justin C.,Good Jerene
Funder
National Cancer Institute
National Center for Advancing Translational Sciences
Basser Center
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Metcalfe KA, Goel V, Lickley L, Semple J, Narod SA (2002) Prophylactic bilateral mastectomy: patterns of practice. Cancer 95(2):236–242
2. Wainberg S, Husted J (2004) Utilization of screening and preventive surgery among unaffected carriers of a BRCA1 or BRCA2 gene mutation. Cancer Epidemiol Biomarkers Prev 13(12):1989–1995
3. Uyei A, Peterson SK, Erlichman J, Broglio K, Yekell S, Schmeler K, Lu K, Meric-Bernstam F, Amos C, Strong L et al (2006) Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study. Cancer 107(12):2745–2751
4. Narod SA (2006) Modifiers of risk of hereditary breast cancer. Oncogene 25(43):5832–5836
5. Eccles DM (2004) Hereditary cancer: guidelines in clinical practice. Breast and ovarian cancer genetics. Ann Oncol 15(Suppl 4:iv):133–138